The deal size was increased to 9.6M shares of common stock from 6.7M shares of common stock. Lake Street acted as sole book running manager for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AYTU:
- Aytu BioPharma enters exclusive agreement with Fabre-Kramer Pharmaceuticals
- Aytu BioPharma prices 9.6M shares at $1.50 in upsized public offering
- Aytu BioPharma announces exclusive commercialization agreement for Exxua
- Aytu BioPharma files to sell 6.74M shares of common stock
- Aytu BioScience Holds 2025 Annual Meeting